An official website of the United States government.

We've made some changes to If the information you are looking for is not here, you may be able to find it on the EPA Web Archive or the January 19, 2017 Web Snapshot.

Assessing and Managing Chemicals under TSCA

Risk Management for Hexabromocyclododecane (HBCD)

Prior to the Lautenberg amendments to the Toxic Substances Control Act (TSCA), EPA took the actions below to address risks from HBCD. Currently, HBCD is undergoing risk evaluation under amended TSCA. In June 2019, EPA published a draft risk evaluation for public comment and peer review. EPA will incorporate comments and feedback in issuing the final risk evaluation. If EPA’s final risk evaluation for HBCD finds unreasonable risks associated with this chemical under specific conditions of use, the Agency will propose actions to address those risks within the timeframe required by TSCA.

Learn more about EPA’s efforts to evaluate the risks of HBCD.

Pre-Lautenberg Actions